UB Paderborn / Katalog / Suche / in CDI

1 – 8 von 8

Sortiert nach

The Use of a Bone Marrow Transplant Program Public Website for Patient Education and Reporting of Outcomes: Increased Use Resulting in Improved Patients' Trust and Assurance

Blood, 2005-11, Vol.106 (11), p.5592-5592

2005

Volltextzugriff (PDF)

Resource Utilization, Costs and Type of Malignancy Associated with Prolonged Length of Stay in Autologous Stem Cell Recipients

Blood, 2004-11, Vol.104 (11), p.5311-5311

2004

Volltextzugriff (PDF)

Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization

Transfusion (Philadelphia, Pa.), 2006-04, Vol.46 (4), p.523-529

2006

Volltextzugriff (PDF)

Triazolinone Biphenylsulfonamide Derivatives as Orally Active Angiotensin II Antagonists with Potent AT1 Receptor Affinity and Enhanced AT2 Affinity

Journal of medicinal chemistry, 1994-08, Vol.37 (17), p.2808-2824

1994

Volltextzugriff (PDF)

A highly potent, orally active imidazo-[4,5-b]pyridine biphenylacylsulfonamide (MK-996;L-159,282) : a new AT1-selective angiotensin II receptor antagonist

Journal of medicinal chemistry, 1994-11, Vol.37 (24), p.4068-4072

1994

Volltextzugriff (PDF)

In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996

American journal of hypertension, 1995-01, Vol.8 (1), p.58-66

1995

Volltextzugriff (PDF)

Inhibition of thermolysin by N-carboxymethyl dipeptides

Biochemical and biophysical research communications, 1981-10, Vol.102 (3), p.963-969

1981

Volltextzugriff (PDF)

In vivo pharmacology of a novel AT 1 selective angiotensin II receptor antagonist, MK-996

American journal of hypertension, 1995, Vol.8 (1), p.58-66

1995

Volltextzugriff (PDF)

1 – 8 von 8

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(8)
Mit Volltextzugriff
(8)

Publikationsform

Artikel
(8)

Sprache

Englisch
(8)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Angiotensin Ii - Antagonists & Inhibitors
(3)
Angiotensin Receptor Antagonists
(3)
Animals
(3)
Biological And Medical Sciences
(3)
Male
(3)
Medical Sciences
(3)
Rats
(3)
Administration, Oral
(2)
Antihypertensive Agents
(2)
Antihypertensive Agents - Pharmacology
(2)
Cardiovascular System
(2)
Dogs
(2)
Enalapril Angiotensin
(2)
Female
(2)
Hypertension
(2)
Imidazoles - Pharmacology
(2)
Kinetics
(2)
Life Sciences & Biomedicine
(2)
Losartan
(2)
Macaca Mulatta
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

American Journal Of Hypertension
(2)
Blood
(2)
Journal Of Medicinal Chemistry
(2)
Biochemical And Biophysical Research Communications
(1)
Transfusion
(1)

Menü

Weitere Dienste

Einstellungen

The Use of a Bone Marrow Transplant Program Public Website for Patient Education and Reporting of Outcomes: Increased Use Resulting in Improved Patients' Trust and Assurance

Resource Utilization, Costs and Type of Malignancy Associated with Prolonged Length of Stay in Autologous Stem Cell Recipients

Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization

Triazolinone Biphenylsulfonamide Derivatives as Orally Active Angiotensin II Antagonists with Potent AT1 Receptor Affinity and Enhanced AT2 Affinity

A highly potent, orally active imidazo-[4,5-b]pyridine biphenylacylsulfonamide (MK-996;L-159,282) : a new AT1-selective angiotensin II receptor antagonist

In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996

Inhibition of thermolysin by N-carboxymethyl dipeptides

In vivo pharmacology of a novel AT 1 selective angiotensin II receptor antagonist, MK-996

Suchergebnisse filtern